Search results
1 Reason to Buy Pfizer Stock After Earnings, and 1 Reason to Sell
Motley Fool· 2 years agoThe year hasn't been kind to equities so far. And although many drugmakers are escaping the...
Lilly (LLY), Incyte's Olumiant Gets FDA Nod for Alopecia Areata
Zacks via Yahoo Finance· 2 years agoEli Lilly LLY and partner Incyte INCY announced that the FDA has granted approval to their oral JAK...
Pfizer (PFE) Q2 Earnings Top, COVID Products Drive Sales
Zacks via Yahoo Finance· 2 years agoPfizer, Inc. PFE reported second-quarter 2022 adjusted earnings per share of $2.04, which beat the...
Pfizer (PFE) to Report Q2 Earnings: What's in the Cards?
Zacks via Yahoo Finance· 2 years agoPfizer PFE will report second-quarter 2022 results on Jul 28, before market open. In the last...
Why Is Pfizer (PFE) Up 6.5% Since Last Earnings Report?
Zacks via Yahoo Finance· 1 year agoIt has been about a month since the last earnings report for Pfizer (PFE). Shares have added about...
Want to Get Richer? 2 Top Stocks to Buy Now and Hold Forever
Motley Fool· 2 years agoFor those who need some inspiration, here are two top companies to look into that could be...
Nature's answer to JAK3 inhibition: Discovering five herbal and natural alternatives
The Gainesville Sun via Yahoo News· 6 months agoJAK3 inhibitors have become a buzzword in pharmaceuticals, with significant implications for...
After FDA, European Agency Limits Use Of Certain JAK Inhibitors Amid Safety Concerns
Benzinga via Yahoo Finance· 2 years agoThe European Medicine Agency's safety committee recommended that a group of JAK inhibitors for...
2 High-Yield Dividend Stocks You Can Buy With $100 Now and Hold Forever
Motley Fool via Yahoo Finance· 1 month agoFew things are more satisfying than watching a steadily growing stream of passive income flow into...
Pfizer Reports Dramatic Declines — But It's Not As Bad As Wall Street Expected
Investor's Business Daily· 1 year agoPfizer stock dipped Tuesday on lighter-than-expected declines in the March quarter, driven almost...